LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) (LIFSCREEN)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by Gustave Roussy, Cancer Campus, Grand Paris
Sponsor:
Information provided by (Responsible Party):
Gustave Roussy, Cancer Campus, Grand Paris
ClinicalTrials.gov Identifier:
NCT01464086
First received: October 31, 2011
Last updated: February 9, 2016
Last verified: February 2016

October 31, 2011
February 9, 2016
September 2011
March 2018   (final data collection date for primary outcome measure)
cancer incidence [ Time Frame: 3 years ] [ Designated as safety issue: No ]
cancer incidence during the first 3 years
Same as current
Complete list of historical versions of study NCT01464086 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)
Not Provided
The purpose of this study is to compare the diagnostic efficacy of two follow-up schedules for the early detection of cancers in the population under study on cancer incidence at 3 years.
Not Provided
Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Li Fraumeni Syndrome
Other: whole body MRI
whole body MRI at inclusion, one and two years
  • No Intervention: Standard arm
    standard follow-up
  • Experimental: Intensive follow-up
    Standard follow-up plus whole body MRI at inclusion, one and two years
    Intervention: Other: whole body MRI
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
110
March 2018
March 2018   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • P53 mutation
Both
5 Years to 71 Years   (Child, Adult, Senior)
No
Contact: Olivier caron 33 1 42 11 51 78 olivier.caron@igr.fr
France
 
NCT01464086
CSET2011/1748
No
Not Provided
Not Provided
Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Cancer Campus, Grand Paris
Not Provided
Not Provided
Gustave Roussy, Cancer Campus, Grand Paris
February 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP